DalsnaFinance › IPOs › AbCellera Biologics › IPO
AbCellera Biologics Inc. completed its initial public offering on NASDAQ on December 11, 2020, pricing at $20.00 a share.
| Ticker | ABCL |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | December 11, 2020 |
| Offering price | $20.00 |
| Shares offered | 24,150,000 |
| Total raised | $483M |
AbCellera Biologics Inc. sold 24,150,000 shares at $20.00 each on NASDAQ. Multiplied out, that is $483 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $483 million total recorded for the deal.
AbCellera Biologics Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for AbCellera Biologics Inc.. This page is general information, not investment advice.